PMD-026

· Phoenix Molecular Designs

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PMD-026, covering 2026-01-21 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer [Phase 1, Phase 2]